Tenax Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -92.5% | +94.8% | -28.1% | -33.8% | +1,090.0% | +7.0% | -5.0% | +4.0% | -93.3% | – | – | |
| – | -19.7% | -147.9% | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +427.6% | -90.0% | -64.9% | +180.1% | +31.4% | +451.4% | -78.6% | -40.0% | +293.6% | +157.1% | |
| – | +0.0% | -12.9% | -9.1% | -0.4% | -10.1% | +4.4% | +42.8% | -25.1% | -11.8% | +35.6% | +249.5% | |
| – | -7.0% | +280.7% | -82.5% | -25.1% | +24.1% | +14.0% | +235.6% | -66.2% | -25.5% | +136.8% | +189.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +66,117.8% | -100.0% | – | – | – | -41.7% | +368.2% | +439.4% | -4.0% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.1% | -3,274.0% | – | – | – | – | +1,192.3% | -101.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.